Literature DB >> 11490528

Idiopathic osteoporosis: a heterogeneous entity.

H M Heshmati1, S Khosla.   

Abstract

DEFINITION: Idiopathic osteoporosis refers to the development of osteopenia and fractures with minimal or no trauma in otherwise young, healthy individuals who are not postmenopausal or have other, identifiable secondary causes of osteoporosis. EPIDEMIOLOGY: It is a relatively rare disorder, with an incidence of 0.4 cases per 100,000 person-years. It appears to affect both sexes equally and results primarily in the development of trabecular bone fractures such as vertebral compression fractures and Colles' fractures, although hip fractures are also seen. PATHOPHYSIOLOGY: The disease may be temporally related to pregnancy and/or lactation in some patients, although it is unclear whether pregnancy plays a pathophysiological role or, more likely, simply leads to the clinical presentation of the disease in individuals who are already affected. Various pathophysiological abnormalities have been described in these patients, including hypercalciuria, abnormalities in vitamin D metabolism, and in the production of insulin-like growth factor I and interleukin 1. Findings on bone biopsy have been variable, with some patients having evidence of a defect in osteoblast function, whereas others having evidence for increased bone resorption. TREATMENT: No specific therapy has been proven to be effective in these patients. However, an individualized approach based on an assessment of bone turnover may be reasonable and may decrease the bone loss and subsequent fracture risk.

Entities:  

Mesh:

Year:  1998        PMID: 11490528

Source DB:  PubMed          Journal:  Ann Med Interne (Paris)        ISSN: 0003-410X


  13 in total

1.  Increased marrow adiposity in premenopausal women with idiopathic osteoporosis.

Authors:  Adi Cohen; David W Dempster; Emily M Stein; Thomas L Nickolas; Hua Zhou; Donald J McMahon; Ralph Müller; Thomas Kohler; Alexander Zwahlen; Joan M Lappe; Polly Young; Robert R Recker; Elizabeth Shane
Journal:  J Clin Endocrinol Metab       Date:  2012-06-14       Impact factor: 5.958

2.  Abnormal bone microarchitecture and evidence of osteoblast dysfunction in premenopausal women with idiopathic osteoporosis.

Authors:  Adi Cohen; David W Dempster; Robert R Recker; Emily M Stein; Joan M Lappe; Hua Zhou; Andreas J Wirth; G Harry van Lenthe; Thomas Kohler; Alexander Zwahlen; Ralph Müller; Clifford J Rosen; Serge Cremers; Thomas L Nickolas; Donald J McMahon; Halley Rogers; Ronald B Staron; Jeanette LeMaster; Elizabeth Shane
Journal:  J Clin Endocrinol Metab       Date:  2011-08-10       Impact factor: 5.958

3.  Teriparatide increases strength of the peripheral skeleton in premenopausal women with idiopathic osteoporosis: a pilot HR-pQCT study.

Authors:  Kyle K Nishiyama; Adi Cohen; Polly Young; Ji Wang; Joan M Lappe; X Edward Guo; David W Dempster; Robert R Recker; Elizabeth Shane
Journal:  J Clin Endocrinol Metab       Date:  2014-03-31       Impact factor: 5.958

4.  Long-term culture in dexamethasone unmasks an abnormal phenotype in osteoblasts isolated from osteoporotic subjects.

Authors:  L G Rao; T M Murray; J N Wylie; R J McBroom; M Kung Sutherland
Journal:  J Endocrinol Invest       Date:  2005-11       Impact factor: 4.256

5.  Premenopausal women with idiopathic low-trauma fractures and/or low bone mineral density.

Authors:  A Cohen; R R Recker; J Lappe; D W Dempster; S Cremers; D J McMahon; E M Stein; J Fleischer; C J Rosen; H Rogers; R B Staron; J Lemaster; E Shane
Journal:  Osteoporos Int       Date:  2011-03-02       Impact factor: 4.507

6.  IGF-1 Receptor Expression on Circulating Osteoblast Progenitor Cells Predicts Tissue-Based Bone Formation Rate and Response to Teriparatide in Premenopausal Women With Idiopathic Osteoporosis.

Authors:  Adi Cohen; Stavroula Kousteni; Brygida Bisikirska; Jayesh G Shah; J Sanil Manavalan; Robert R Recker; Joan Lappe; David W Dempster; Hua Zhou; Donald J McMahon; Mariana Bucovsky; Mafo Kamanda-Kosseh; Julie Stubby; Elizabeth Shane
Journal:  J Bone Miner Res       Date:  2017-03-23       Impact factor: 6.741

Review 7.  Idiopathic osteoporosis in men.

Authors:  Luigi Gennari; John P Bilezikian
Journal:  Curr Osteoporos Rep       Date:  2013-12       Impact factor: 5.096

8.  Bone Density After Teriparatide Discontinuation in Premenopausal Idiopathic Osteoporosis.

Authors:  Adi Cohen; Mafo Kamanda-Kosseh; Robert R Recker; Joan M Lappe; David W Dempster; Hua Zhou; Serge Cremers; Mariana Bucovsky; Julie Stubby; Elizabeth Shane
Journal:  J Clin Endocrinol Metab       Date:  2015-09-10       Impact factor: 5.958

9.  Whole exome sequencing reveals potentially pathogenic variants in a small subset of premenopausal women with idiopathic osteoporosis.

Authors:  Adi Cohen; Joseph Hostyk; Evan H Baugh; Christie M Buchovecky; Vimla S Aggarwal; Robert R Recker; Joan M Lappe; David W Dempster; Hua Zhou; Mafo Kamanda-Kosseh; Mariana Bucovsky; Julie Stubby; David B Goldstein; Elizabeth Shane
Journal:  Bone       Date:  2021-11-04       Impact factor: 4.398

10.  Effects of physical training on bone mineral density in fertile women with idiopathic osteoporosis.

Authors:  Ingrid Bergström; Jonas Brinck; Maria Sääf
Journal:  Clin Rheumatol       Date:  2008-04-29       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.